Keywords: strong, 24-month, performance, gsk, advodart, uk, drug

Strong 24-month performance for GSK's Advodart

Article | 10 September 2007

Print This

UK drug major GlaxoSmithKline says that results from a large study demonstrates that combination treatment with Avodart (dutasteride) and the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in